Boardroom Alpha
Boardroom Alpha
LGN · Current Report (Form 8-K) · Filed December 5, 2025

Legence Corp — Current Report (Form 8-K)

Form
8-K
Filed
December 5, 2025
Period
Dec 3, 2025
Ticker
LGN
Accession
0001193125-25-308561
Boardroom Alpha · Filing insights

Board expands to six and appoints David Coghlan as Class I director, Audit Committee member, and Compensation Chair; independence confirmed.

About Legence Corp
Market cap
$9.2B
Board grade
C+
Sector
Industrials
CEO
Jeffrey Sprau
Last annual meeting: Jun 11, 2026 · View full Legence Corp profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 3, 2025

 

 

Legence Corp.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-42838   33-2905250

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

1601 Las Plumas Avenue

San Jose, CA

  95133
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (833) 534-3623

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Class A common stock, par value $0.01 per share   LGN   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 3, 2025, the Board of Directors (the “Board”) of Legence Corp., a Delaware corporation (the “Company”), increased the size of the Board from five to six directors and appointed Mr. David J. Coghlan to the Board as a Class I director to fill the vacancy created by such increase, effective as of December 3, 2025. The Board also appointed Mr. Coghlan to serve on the Board’s Audit Committee and as chair of Board’s Compensation Committee. As a Class I director, Mr. Coghlan will serve for an initial term that will expire at the annual meeting of shareholders in 2026 or upon his death, resignation, retirement or removal.

Mr. Coghlan, age 66, has extensive global experience in executive and non-executive advisory roles, with a focus on corporate strategy development and execution, talent development, organic and inorganic growth and operational excellence. He has been a board member of Justrite Safety Group, a global leader in industrial safety solutions, since September 2021 and currently serves on other private company boards based out of New Jersey and Michigan. Mr. Coghlan previously served as Senior Managing Director of Madison Industries from April 2014 to April 2021, where he also chaired various privately held companies between 2015 and 2021. Before that, Mr. Coghlan previously served as Watts Water Technologies, Inc.’s (NYSE: WTS) Chief Executive Officer and President from January 2011 to February 2014, Chief Operating Officer from January 2010 to January 2011 and President of North America and Asia from June 2008 to January 2010. Prior to that, Mr. Coghlan served as Vice President of Global Parts for Trane Inc. from April 2004 to May 2008. Mr. Coghlan also held several management positions in the United States and internationally within the Climate Control Technologies segment of Ingersoll-Rand Company Limited from 1995 to December 2003. Before joining Ingersoll-Rand Company Limited, Mr. Coghlan worked for several years with the management consulting firm of McKinsey & Co. in both the United Kingdom and the United States. Mr. Coghlan has a Bachelor of Commerce in Finance from the University College Dublin and a graduate degree in Marketing from the Marketing Institute of Ireland.

The Board, after consideration of all facts and circumstances, affirmatively determined that Mr. Coghlan meets the independence requirements under the rules of the Nasdaq Stock Market LLC, as well as the applicable rules promulgated by the Securities and Exchange Commission (the “Commission”) and the Company’s guidelines for determining director independence.

In connection with his election, Mr. Coghlan will receive the standard annual compensation for the Company’s non-management directors. Such annual compensation includes (i) a cash retainer in the amount of $85,000 per year, (ii) an award of restricted stock units covering a certain number of shares of the Company’s Class A common stock par value $0.01 per share, valued at approximately $150,000 as of the grant date and (iii) an additional cash retainer in the amount of $15,000 per year for his service as chair of the Board’s Compensation Committee.

In connection with his appointment, the Company entered into its standard form of indemnification agreement with Mr. Coghlan, the form of which has been included in the Company’s Registration Statement on Form S-1 (File No. 333-289629) that was filed with the Commission on August 15, 2025.

There were no understandings or other agreements or arrangements between Mr. Coghlan, on the one hand, and any other person, on the other hand, pursuant to which he was appointed as a director of the Company. Furthermore, there are no transactions between Mr. Coghlan and the Company that would be required to be reported under Item 404(a) of Regulation S-K.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    LEGENCE CORP.
Dated: December 5, 2025     By:  

/s/ Jeffrey Sprau

    Name:   Jeffrey Sprau
    Title:   Chief Executive Officer
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Legence Corp (LGN)

Reference

Frequently asked questions

When did Legence Corp file this 8-K?
Legence Corp (LGN) filed this Current Report (Form 8-K) with the SEC on December 5, 2025. The accession number assigned by EDGAR is 0001193125-25-308561.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Board expands to six and appoints David Coghlan as Class I director, Audit Committee member, and Compensation Chair; independence confirmed. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Legence Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Legence Corp has filed under CIK 2052568, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer